Ubrelvy (ubrogepant) was the first oral CGRP receptor antagonist approved for the acute treatment of migraine in adults. What you need to know now, especially if you can't take triptans.

A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial has found. People who took ...

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Attorneys with ...

- More patients treated with UBRELVY ® 100 mg during the prodrome avoided the development of moderate or severe headache within 24 hours post-dose vs. placebo in those who could identify prodrome ...

The Food and Drug Administration (FDA) has recently intervened regarding a migraine medication advertisement featuring tennis superstar Serena Williams. The FDA’s concerns center around claims that ...

On August 29, 2024, the U.S. Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) issued an untitled letter to AbbVie, Inc. (AbbVie) regarding a promotional, ...

MINIMIZED WHEN POSSIBLE. WELL, IN TONIGHT’S WOMAN’S DOCTOR, IF YOU’RE A MIGRAINE SUFFERER, A NEW MEDICATION NOW IN THE MARKET IS INTENDED TO FOCUS ON THOSE EXTREME HEADACHES. MERCY MEDICAL CENTER ...

If only there were a magical pill you could pop to make migraine symptoms go away permanently—a one-and-done migraine medication that would eradicate headaches forever. But if you’re someone who’s ...